Gan & Lee Pharmaceuticals Co Ltd (603087) — Cash Flow Reinvestment Rate
Gan & Lee Pharmaceuticals Co Ltd (603087) has a Cash Flow Reinvestment Rate of 1.01x as of September 2025, reinvesting CN¥260.89 Million (capex CN¥260.89 Million ) from operating cash flow of CN¥257.27 Million. See Gan & Lee Pharmaceuticals Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gan & Lee Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Gan & Lee Pharmaceuticals Co Ltd across 13 annual periods. For the full cash flow conversion analysis, see Gan & Lee Pharmaceuticals Co Ltd (603087) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Gan & Lee Pharmaceuticals Co Ltd (2013–2025)
Year-by-year capital reinvestment analysis for Gan & Lee Pharmaceuticals Co Ltd. See Gan & Lee Pharmaceuticals Co Ltd (603087) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.01x | CN¥1.58 Billion | CN¥784.28 Million | CN¥926.09 Million | ▲ +75.2% |
| 2024 | 1.15x | CN¥616.97 Million | CN¥537.31 Million | CN¥440.80 Million | ▼ -67.9% |
| 2023 | 3.58x | CN¥1.53 Billion | CN¥427.69 Million | CN¥553.06 Million | ▼ -19.1% |
| 2022 | 4.42x | CN¥1.31 Billion | CN¥296.68 Million | CN¥983.44 Million | ▲ +535.4% |
| 2021 | 0.70x | CN¥750.31 Million | CN¥1.08 Billion | CN¥692.08 Million | ▼ -73.4% |
| 2020 | 2.61x | CN¥3.24 Billion | CN¥1.24 Billion | CN¥582.14 Million | ▲ +139.7% |
| 2019 | 1.09x | CN¥1.26 Billion | CN¥1.15 Billion | CN¥406.63 Million | ▼ -31.2% |
| 2018 | 1.59x | CN¥662.64 Million | CN¥418.04 Million | CN¥513.44 Million | ▲ +103.0% |
| 2017 | 0.78x | CN¥741.52 Million | CN¥949.60 Million | CN¥431.02 Million | ▼ -5.1% |
| 2016 | 0.82x | CN¥633.34 Million | CN¥769.63 Million | CN¥258.48 Million | ▼ -0.1% |
| 2015 | 0.82x | CN¥368.43 Million | CN¥447.42 Million | CN¥368.43 Million | ▼ -20.3% |
| 2014 | 1.03x | CN¥315.47 Million | CN¥305.22 Million | CN¥315.47 Million | ▲ +111.5% |
| 2013 | 0.49x | CN¥100.06 Million | CN¥204.73 Million | CN¥100.06 Million | — |